AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Angiogenix acquires nitrate products.
2003 FEB 10 - (NewsRx.com & NewsRx.net) -- Angiogenix, Inc., a privately held, biopharmaceutical company developing products for peripheral and cardiac ischemia, announced that it had acquired Acclaim from NitrOSystems, Inc.
Acclaim is a proprietary nitrate that could replace a significant share of existing generic nitrate products whose worldwide sales are about $3 billion.
A clinical study by John O. Parker, MD, FACC, et al published in the April 3, 2002, issue of the Journal of the American College of Cardiology, showed that the active ingredients in Acclaim prevented development of nitrate tolerance. According to Kenneth J. Colley, MD, PhD, founder of …
- Angiogenix Acquires Nitrate Products.
- Press release article from: PR Newswire December 10, 2002 700+ words
...However, current nitrate products require a daily...currently." Nitrate Products Nitrates have...drugs stimulate nitric oxide synthase...the amount of nitric oxide is diminished...existing generic nitrate products with worldwide...
- NitrOSystems Inc., Pharmaceutical Technologies Company Formed.
- Press release article from: PR Newswire May 4, 2000 700+ words
...Laureates discovered that nitric oxide, the substance long...The future of nitric oxide will be centered around...basic science regarding nitric oxide production allows it to manufacture nitrate products that we believe will...
- Pharmaceutical Technologies Company Secures U.S., Australian Patents.
- Press release article from: PR Newswire May 18, 2000 700+ words
...science regarding nitric oxide production will...manufacture nitrate products that they believe...tolerance. Nitric oxide synthase is...for producing nitric oxide from its conversion...regimens for nitrate products require a nitrate...
- Specialty Pharmaceutical Company Announces Research Results.
- Press release article from: PR Newswire October 18, 2000 700+ words
...develops products that stimulate nitric oxide in the coronary arteries. The...NitrOSystems' next generation nitrate products will resolve the primary limitation...that stimulate the production of nitric oxide by endothelial cells. The company...
Source: HighBeam Research, Angiogenix acquires nitrate products.
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
